Protocol Ledger

NCT06095765 · Phase III · RECRUITING

Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention

Interventional Phase III clinical trial protocol NCT06095765 sponsored by AZ Sint-Jan AV in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-01-29 Enrollment: 2,770 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06095765
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)2,770 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06095765
Protocol FieldVerified Registry Value
NCT IdentifierNCT06095765
Consolidated Lead SponsorAZ Sint-Jan AV
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment2,770 participants (ESTIMATED)
Registered Start Date2024-01-29
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06095765
Hospital Research SiteLocationSite Profile
Universitair Ziekenhuis GentGhent, BelgiumOpen Hospital Dossier ->
UZ LeuvenLeuven, BelgiumOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI